Previous Close | 543.61 |
Open | 543.89 |
Bid | 552.58 x 800 |
Ask | 552.91 x 900 |
Day's Range | 543.89 - 553.07 |
52 Week Range | 373.28 - 566.01 |
Volume | |
Avg. Volume | 672,337 |
Market Cap | 71.705B |
Beta (5Y Monthly) | 0.45 |
PE Ratio (TTM) | 24.63 |
EPS (TTM) | N/A |
Earnings Date | N/A |
Forward Dividend & Yield | 2.48 (0.46%) |
Ex-Dividend Date | Jun 03, 2024 |
1y Target Est | N/A |
Investors in McKesson Corporation ( NYSE:MCK ) had a good week, as its shares rose 2.4% to close at US$544 following...
McKesson's (MCK) fourth-quarter fiscal 2024 results showcase growth in the U.S. Pharmaceutical while lower COVID-related sales hurt the Medical Surgical Solutions segment.
McKesson Corporation (NYSE:MCK) Q4 2024 Earnings Call Transcript May 7, 2024 McKesson Corporation misses on earnings expectations. Reported EPS is $6.18 EPS, expectations were $6.36. McKesson Corporation isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Please stand by. Welcome to […]